Erythropoietin and its non-erythropoietic derivative: Do they ameliorate renal tubulointerstitial injury in ureteral obstruction?

International Journal of Urology

Volumn 15, Issue 11, 2008, Pages 1011-1017

  Srisawat, Nattachai ^a   Manotham, Krissanapong ^b   Eiam Ong, Somchit ^a   Katavetin, Pisut ^a   Praditpornsilpa, Kearkiat ^a   Eiam Ong, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b LERDSIN GENERAL HOSPITAL   (Thailand)

Author keywords

Carbamylated erythropoietin; Erythropoietin; Tubulointerstitial injury; Unilateral ureteral obstruction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBAMYLERYTHROPOIETIN; COLLAGEN TYPE 4; MESSENGER RNA; PROTEIN BCL 2; RECOMBINANT ERYTHROPOIETIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; GEL ELECTROPHORESIS; HEMATOCRIT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE DAMAGE; MACROPHAGE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SPECTROPHOTOMETRY; URETER OBSTRUCTION;

ANIMALS; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; RATS; RATS, SPRAGUE-DAWLEY; URETERAL OBSTRUCTION;

EID: 54849412101     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02149.x     Document Type: Article

References (25)

1. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern. Med. 2004 43 : 9 14.
2. Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988 71 : 524 7.
3. Sharples EJ, Patel N, Brown P et al. l. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 2004 15 : 2115 24.
4. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci 2005 6 : 484 94.
5. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2006 2 : 157 68.
6. Ito K, Chen J, El Chaar M et al. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am. J. Physiol. Renal Physiol. 2004 287 : F1283 93.
7. Park KD, Mun KC, Chang EJ, Park SB, Kim HC. Inhibition of erythropoietin activity by cyanate. Scand. J. Urol. Nephrol. 2004 38 : 69 72.
8. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J. Am. Soc. Nephrol. 2001 12 : 1434 47.
9. Manotham K, Tanaka T, Ohse T et al. A biologic role of HIF-1 in the renal medulla. Kidney Int. 2005 67 : 1428 39.
10. Chatterjee PK. Pleiotropic renal actions of erythropoietin. Lancet 2005 365 : 1890 2.
11. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004 110 : 1006 12.
12. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004 66 : 753 60.
13. Rossert J, Levin A, Roger SD et al. Effect of early correction of anemia on the progression of CKD. Am. J. Kidney Dis. 2006 47 : 738 50.
14. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004 66 : 983 9.
15. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol. Dial. Transplant. 2004 19 : 348 55.
16. Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003 17 : 1754 5.
17. Lebel M, Rodrigue ME, Agharazii M, Lariviere R. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am. J. Hypertens. 2006 19 : 1286 92.
18. Lee SH, Li C, Lim SW et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am. J. Nephrol. 2005 25 : 64 76.
19. Chevalier RL Specific molecular targeting of renal injury in obstructive nephropathy. Kidney Int. 2006 70 : 1200 1.
20. Imamura R, Isaka Y, Ichimaru N, Takahara S, Okuyama A. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem. Biophys. Res. Commun. 2007 353 : 786 92.
21. Leist M, Ghezzi P, Grasso G et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004 305 : 239 42.
22. Kawada N, Moriyama T, Ando A et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 1999 56 : 1004 13.
23. Katavetin P, Inagi R, Miyata T et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem. Biophys. Res. Commun. 2007 359 : 928 34.
24. Deshane J, Wright M, Agarwal A. Heme oxygenase-1 expression in disease states. Acta Biochim. Pol. 2005 52 : 273 84.
25. Kitamura H, Isaka Y, Takabatake Y et al. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Nephrol. Dial. Transplant. 2008 23 : 1521 8.